Clinical trial
Re-setting the Breast Microbiome to Lower Inflammation and Risk of Cancer.
NCT03290651 is registered in ClinicalTrials.gov with London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Re-setting the Breast Microbiome to Lower Inflammation and Risk of Cancer.
- Lead sponsor
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 2, 2019
- Completion date
- December 31, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
breast cancer female